Raymond James Upgrades PTC Therapeutics (PTCT) to Market Perform

Go back to Raymond James Upgrades PTC Therapeutics (PTCT) to Market Perform

PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation

May 20, 2024 7:00 AM EDT

- European Commission decides against adoption of negative opinion -

- Translarna authorization remains active in Europe -

- 2024 revenue guidance paused -

WARREN, N.J., May 20, 2024 /PRNewswire/ -- PTC Therapeutics, Inc.... More